Pharmafile Logo

Succeeding with Star Wars Medicine

May 5, 2020 |  

OPEN Health have published a new white paper demonstrating their commitment to leading the conversation on how effective healthcare communications, and tools that enable them, can lead to faster and sustained patient access to gene and other advanced therapies. We brought together experience and capabilities from across our practices to develop broad thinking on ‘Succeeding with Star Wars Medicine – translating the science and value of gene therapy to key stakeholders’. The thinking is based on three key foundations:

  • Leading a patient first approach
  • Communicating the science
  • Demonstrating Value
Pink divider

Please find below a link to a short video of our director of rare disease, Gavin Jones, describing why we have invested in this white paper and what you can expect from our recommendations.

Video link –  https://vimeo.com/414772814

Pink divider

To arrange a virtual presentation to discuss the findings and to receive a copy of the white paper please contact: gavinjones@openhealthgroup.com

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health expands offering with the launch of a new Learning & Development specialist team

Enhanced expertise to deliver impactful internal training programmes for healthcare clients

Spotlight interview: 15 minutes on healthcare communications in gene therapy

Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy

OPEN Health becomes sponsor of MedComms Networking

New for 2020, OPEN Health is pleased to announce its sponsorship of MedComms Networking

OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications

Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications

Spotlight interview: 15 minutes on digital in medical communications

Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications

Generating data on long-term outcomes with gene and other advanced therapies

Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

Spotlight interview: 15 minutes on insights and market research in pharma

Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma

OPEN Health reflections on the World Orphan Drug Congress in Barcelona

Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...